Rui Wei

4.9k total citations · 1 hit paper
116 papers, 3.6k citations indexed

About

Rui Wei is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Rui Wei has authored 116 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 46 papers in Surgery and 31 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Rui Wei's work include Pancreatic function and diabetes (37 papers), Diabetes Treatment and Management (19 papers) and Diabetes Management and Research (14 papers). Rui Wei is often cited by papers focused on Pancreatic function and diabetes (37 papers), Diabetes Treatment and Management (19 papers) and Diabetes Management and Research (14 papers). Rui Wei collaborates with scholars based in China, Hong Kong and United States. Rui Wei's co-authors include Wenjun Ding, Fang Zhang, Tianpei Hong, Xiaobei Deng, Jin Yang, Li Min, Shutian Zhang, Deliang Chen, Fang Long and Lijuan Wang and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Rui Wei

110 papers receiving 3.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The neutrophil-to-lymphocyte ratio is associated with all-cause and cardiovascular mortality among individuals with hypertension

2024 70 citations Rui Wei et al. Cardiovascular Diabetology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Rui Wei	1.6k	880	696	685	475	116	3.6k
Changcheng Zhou	1.0k 0.6×	503 0.6×	445 0.6×	626 0.9×	399 0.8×	101	3.4k
Jie Liu	1.7k 1.1×	936 1.1×	650 0.9×	267 0.4×	713 1.5×	187	5.4k
Jeffrey A. Deiuliis	774 0.5×	960 1.1×	274 0.4×	548 0.8×	392 0.8×	38	3.2k
William A. Ricke	1.4k 0.9×	647 0.7×	258 0.4×	714 1.0×	590 1.2×	119	4.7k
Ze Zheng	891 0.5×	589 0.7×	435 0.6×	307 0.4×	196 0.4×	61	3.1k
Sonia Saad	1.1k 0.7×	381 0.4×	222 0.3×	276 0.4×	197 0.4×	105	3.0k
Frank Thévenod	2.1k 1.3×	2.1k 2.4×	674 1.0×	169 0.2×	211 0.4×	127	5.9k
Donald A. Sens	1.9k 1.2×	1.6k 1.8×	336 0.5×	206 0.3×	272 0.6×	143	4.5k
Xiaoquan Rao	661 0.4×	1.4k 1.6×	267 0.4×	496 0.7×	135 0.3×	60	3.5k
Federico M. Farin	1.2k 0.7×	499 0.6×	208 0.3×	300 0.4×	287 0.6×	86	4.0k

Countries citing papers authored by Rui Wei

Since Specialization

Citations

This map shows the geographic impact of Rui Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Wei more than expected).

Fields of papers citing papers by Rui Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Wei. The network helps show where Rui Wei may publish in the future.

Co-authorship network of co-authors of Rui Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Wei. A scholar is included among the top collaborators of Rui Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Wei. Rui Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

J, Li, Dandan Wang, Fei Li, et al.. (2025). Mulberry twig (Sangzhi) alkaloids induce pancreatic α-to-β-cell phenotypic conversion in type 2 diabetic mice. Phytomedicine. 141. 156685–156685. 1 indexed citations

Wei, Rui, et al.. (2025). Anti-CD3 monoclonal antibody in treating patients with type 1 diabetes: an updated systematic review and meta-analysis. Cardiovascular Diabetology. 24(1). 146–146. 1 indexed citations

Yang, Jin, Yafei Jiang, Tianjiao Wei, et al.. (2024). SGLT2 inhibitors ameliorate NAFLD in mice via downregulating PFKFB3, suppressing glycolysis and modulating macrophage polarization. Acta Pharmacologica Sinica. 45(12). 2579–2597. 26 indexed citations

Li, Xia, et al.. (2024). Evaluating the Safety and Efficacy of Sodium-Glucose Co-transporter 2 Inhibitors in Subjects with Prediabetes: A Protocol for a Randomized Controlled Trial. Diabetes Therapy. 15(5). 1231–1244.

Chen, Xi, Zhenzhong Zhang, Lingling Wang, et al.. (2024). Homodimeric peptide radiotracer [68Ga]Ga-NOTA-(TMVP1)2 for VEGFR-3 imaging of cervical cancer patients. European Journal of Nuclear Medicine and Molecular Imaging. 51(8). 2338–2352. 6 indexed citations

Yang, Jin, Xia Li, Tianjiao Wei, et al.. (2024). Gut Microbiota−Tryptophan Metabolism−GLP-1 Axis Participates in β-Cell Regeneration Induced by Dapagliflozin. Diabetes. 73(6). 926–940. 19 indexed citations

Zhu, Bin, et al.. (2024). A-to-I RNA editing of CYP18A1 mediates transgenerational wing dimorphism in aphids. eLife. 13. 1 indexed citations

Yang, Cheng, et al.. (2023). Application of Matrigel in the 3-dimension culture of female germline stem cells. Reproductive Biology. 23(3). 100769–100769. 1 indexed citations

Wei, Rui, Xiaona Cui, Zongzhe Jiang, et al.. (2023). Fatty acid β‐oxidation and mitochondrial fusion are involved in cardiac microvascular endothelial cell protection induced by glucagon receptor antagonism in diabetic mice. Journal of Diabetes. 15(12). 1081–1094. 2 indexed citations

10.

Wei, Tianjiao, Xiaona Cui, Dandan Wang, et al.. (2023). Glucagon Acting at the GLP-1 Receptor Contributes to β-Cell Regeneration Induced by Glucagon Receptor Antagonism in Diabetic Mice. Diabetes. 72(5). 599–610. 29 indexed citations

11.

Le, Yunyi, Jin Yang, Fei Li, et al.. (2022). Dapagliflozin improves pancreatic islet function by attenuating microvascular endothelial dysfunction in type 2 diabetes. Diabetes/Metabolism Research and Reviews. 39(3). e3607–e3607. 5 indexed citations

12.

Cui, Xiaona, Fei Li, Xia Li, et al.. (2022). Glucagon receptor blockage inhibits β-cell dedifferentiation through FoxO1. American Journal of Physiology-Endocrinology and Metabolism. 324(1). E97–E113. 8 indexed citations

13.

Cui, Xiaona, Jin Feng, Tianjiao Wei, et al.. (2022). Pancreatic alpha cell glucagon–liver FGF21 axis regulates beta cell regeneration in a mouse model of type 2 diabetes. Diabetologia. 66(3). 535–550. 25 indexed citations

14.

Gu, Liangbiao, Dandan Wang, Xiaona Cui, et al.. (2021). Combination of GLP-1 Receptor Activation and Glucagon Blockage Promotes Pancreatic β-Cell Regeneration In Situ in Type 1 Diabetic Mice. Journal of Diabetes Research. 2021. 1–10. 5 indexed citations

15.

Yang, Kun, Rui Wei, Wenhua Xiao, et al.. (2021). High baseline FGF21 levels are associated with poor glucose-lowering efficacy of exenatide in patients with type 2 diabetes. Acta Diabetologica. 58(5). 595–602. 6 indexed citations

16.

Zhu, Bin, Linhong Li, Rui Wei, Pei Liang, & Xiwu Gao. (2021). Regulation of GSTu1-mediated insecticide resistance in Plutella xylostella by miRNA and lncRNA. PLoS Genetics. 17(10). e1009888–e1009888. 51 indexed citations

17.

Lang, Shan, Rui Wei, Tianjiao Wei, et al.. (2020). Glucagon receptor antagonism promotes the production of gut proglucagon-derived peptides in diabetic mice. Peptides. 131. 170349–170349. 17 indexed citations

18.

Gu, Liangbiao, Xiaona Cui, Shan Lang, et al.. (2019). Glucagon receptor antagonism increases mouse pancreatic δ-cell mass through cell proliferation and duct-derived neogenesis. Biochemical and Biophysical Research Communications. 512(4). 864–870. 17 indexed citations

19.

Liu, Junling & Rui Wei. (2017). Implication of proinsulin to insulin ratio in the basic and clinical research of diabetes. Zhonghua neifenmi daixie zazhi. 33(5). 449–452. 1 indexed citations

20.

Yuan, Jun, et al.. (2011). A Randomized study on the Effects of Paclitaxel Liposme and Cisplatin Induction Chemotherapy Followed Concurrent Chemoradiotherapy and Sequential Radiotherapy on Locally Advanced Non-small Cell Lung Cancer Patients. SHILAP Revista de lepidopterología. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact